Alx Oncology Holdings (ALXO) Other Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 37.7% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 37.7% YoY), while the FY2025 annual figure was $4.0 million, down 35.68% from the prior year.
• Other Non-Current Liabilities came in at $3.5 million for Q1 2026 at Alx Oncology Holdings, down from $4.0 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $7.2 million in Q4 2023 to a low of $3.5 million in Q1 2026.
• A 5-year average of $5.7 million and a median of $5.7 million in 2022 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities surged 1506.73% in 2022 and plunged 37.7% in 2026, its largest moves.
• Alx Oncology Holdings' Other Non-Current Liabilities stood at $5.3 million in 2022, then surged by 35.59% to $7.2 million in 2023, then fell by 14.07% to $6.2 million in 2024, then slumped by 35.68% to $4.0 million in 2025, then declined by 11.86% to $3.5 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $3.5 million, $4.0 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison